MDMA-assisted psychotherapy for treatment of anxiety and other psychological distress related to life-threatening illnesses: a randomized pilot study

MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials

(2019) Michael C. Mithoefer et al.   PSYCHOPHARMACOLOGY

MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?

(2018) Allison A. Feduccia et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Reduction in social anxiety after MDMA-assisted psychotherapy with autistic adults: a randomized, double-blind, placebo-controlled pilot study

(2018) Alicia L. Danforth et al.   PSYCHOPHARMACOLOGY

3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial

(2018) Marcela Ot’alora G et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Safety pharmacology of acute MDMA administration in healthy subjects

(2017) Patrick Vizeli et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Altered Insula Connectivity under MDMA

(2017) Ishan C Walpola et al.   NEUROPSYCHOPHARMACOLOGY

Inhibition of serotonin transporters disrupts the enhancement of fear memory extinction by 3,4-methylenedioxymethamphetamine (MDMA)

(2017) Matthew B. Young et al.   PSYCHOPHARMACOLOGY

Progress and promise for the MDMA drug development program

(2017) Allison A. Feduccia et al.   PSYCHOPHARMACOLOGY

Posttraumatic stress-related psychological functioning in adult survivors of childhood cancer

(2017) Jennifer Allen et al.   Journal of Cancer Survivorship

Psycho-existential distress in cancer patients: A return to “entheogens”

(2016) Craig D Blinderman   JOURNAL OF PSYCHOPHARMACOLOGY

Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial

(2016) Roland R Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial

(2016) Stephen Ross et al.   JOURNAL OF PSYCHOPHARMACOLOGY

The Effects of Acutely Administered 3,4-Methylenedioxymethamphetamine on Spontaneous Brain Function in Healthy Volunteers Measured with Arterial Spin Labeling and Blood Oxygen Level–Dependent Resting State Functional Connectivity

(2015) Robin L. Carhart-Harris et al.   BIOLOGICAL PSYCHIATRY

The prosocial effects of 3,4-methylenedioxymethamphetamine (MDMA): Controlled studies in humans and laboratory animals

(2015) Philip Kamilar-Britt et al.   NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS

3,4-Methylenedioxymethamphetamine facilitates fear extinction learning

(2015) M B Young et al.   Translational Psychiatry

Safety and Efficacy of Lysergic Acid Diethylamide-Assisted Psychotherapy for Anxiety Associated With Life-threatening Diseases

(2014) Peter Gasser et al.   JOURNAL OF NERVOUS AND MENTAL DISEASE

Hastalık Algısı Myokard İnfarktüsü Geçiren Hastalarda Travma Sonrası Stres Bozukluğunu Öngörebilir mi?

(2014) Serap OFLAZ et al.   Noropsikiyatri Arsivi-Archives of Neuropsychiatry

The effect of acutely administered MDMA on subjective and BOLD-fMRI responses to favourite and worst autobiographical memories

(2013) R. L. Carhart-Harris et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Correlates of Post-traumatic Stress Disorder in Stroke Survivors

(2013) Judith Z. Goldfinger et al.   Journal of Stroke & Cerebrovascular Diseases

MDMA enhances emotional empathy and prosocial behavior

(2013) Cédric M. Hysek et al.   Social Cognitive and Affective Neuroscience

Durability of improvement in post-traumatic stress disorder symptoms and absence of harmful effects or drug dependency after 3,4-methylenedioxymethamphetamine-assisted psychotherapy: a prospective long-term follow-up study

(2012) Michael C Mithoefer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

A randomized, controlled pilot study of MDMA (±3,4-Methylenedioxymethamphetamine)-assisted psychotherapy for treatment of resistant, chronic Post-Traumatic Stress Disorder (PTSD)

(2012) Peter Oehen et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of Acute MDMA Intoxication on Mood and Impulsivity: Role of the 5-HT2 and 5-HT1 Receptors

(2012) Janelle H. P. van Wel et al.   PLoS One

Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer

(2010) Charles S. Grob et al.   ARCHIVES OF GENERAL PSYCHIATRY

The safety and efficacy of ±3,4-methylenedioxymethamphetamine-assisted psychotherapy in subjects with chronic, treatment-resistant posttraumatic stress disorder: the first randomized controlled pilot study

(2010) Michael C Mithoefer et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Effects of MDMA on sociability and neural response to social threat and social reward

(2009) Gillinder Bedi et al.   PSYCHOPHARMACOLOGY

Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3,4-methylenedioxymethamphetamine) administration

(2009) G. J. H. Dumont et al.   Social Neuroscience

Mystical-type experiences occasioned by psilocybin mediate the attribution of personal meaning and spiritual significance 14 months later

(2008) RR Griffiths et al.   JOURNAL OF PSYCHOPHARMACOLOGY